Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Aluminium sulfate 20% liquid
1310050A0AAAAAA
|
Aluminium sulfate | Aluminium sulfate | Skin | No data available |
|
Aluminium sulfate 20% spray
1303000ABAAAAAA
|
Aluminium sulfate | Aluminium sulfate | Skin | No data available |
|
Alunbrig 180mg tablets
0801050CPBBAAAA
|
Alunbrig | Brigatinib | Malignant Disease and Immunosuppression | No data available |
|
Alunbrig 30mg tablets
0801050CPBBABAB
|
Alunbrig | Brigatinib | Malignant Disease and Immunosuppression | No data available |
|
Alunbrig 90mg tablets
0801050CPBBACAC
|
Alunbrig | Brigatinib | Malignant Disease and Immunosuppression | No data available |
|
Alunbrig 90mg/180mg tablets treatment initiation pack
0801050CPBBADAD
|
Alunbrig | Brigatinib | Malignant Disease and Immunosuppression | No data available |
|
Alupent 10mg/5ml syrup
0301012S0BBABAG
|
Alupent | Orciprenaline sulfate | Respiratory System | No data available |
|
Alupent 20mg tablets
0301012S0BBAAAF
|
Alupent | Orciprenaline sulfate | Respiratory System | No data available |
|
Alymsys 100mg/4ml concentrate for inf vials
0801050APBEAAAA
|
Alymsys | Bevacizumab | Malignant Disease and Immunosuppression | No data available |
|
Alymsys 400mg/16ml concentrate for inf vials
0801050APBEABAB
|
Alymsys | Bevacizumab | Malignant Disease and Immunosuppression | No data available |
|
Alzhok 10mg soluble tablets
0411000G0BGAAAH
|
Alzhok | Memantine hydrochloride | Central Nervous System | No data available |
|
Alzhok soluble tablets treatment initiation pack
0411000G0BGACA0
|
Alzhok | Memantine hydrochloride | Central Nervous System | No data available |
|
Amantadine 100mg tablets
0503040C0AAABAB
|
Amantadine hydrochloride (Antiviral) | Amantadine hydrochloride | Infections | No data available |
|
Amaranth solution
190800000AABMBM
|
Generic compound preparation BNF 1908000 | Other colour, flavour and sweetening preparations | Other Drugs and Preparations | No data available |
|
Amaryl 1mg tablets
0601021A0BBABAB
|
Amaryl | Glimepiride | Endocrine System | No data available |
|
Amaryl 2mg tablets
0601021A0BBAAAA
|
Amaryl | Glimepiride | Endocrine System | No data available |
|
Amaryl 3mg tablets
0601021A0BBACAC
|
Amaryl | Glimepiride | Endocrine System | No data available |
|
Amaryl 4mg tablets
0601021A0BBADAD
|
Amaryl | Glimepiride | Endocrine System | No data available |
|
AmBisome Liposomal powder for dispersion for inf vials
0502030A0BDAAAI
|
AmBisome | Amphotericin | Infections | No data available |
|
Ambre Solaire aftersun skin soother lotion
190205500BBJCA0
|
Proprietary compound preparation BNF 1902055 | Other toiletry preparations | Other Drugs and Preparations | No data available |
|
Ambre Solaire Total screen intolerance milk SPF 60
130801000BBLBA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | No data available |
|
Ambre Solaire UV Sensitive protection spray SPF 50+
130801000BBPJA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | No data available |
|
Ambrisentan 10mg tablets
0205010X0AAABAB
|
Ambrisentan | Ambrisentan | Cardiovascular System | No data available |
|
Ambrisentan 2.5mg tablets
0205010X0AAACAC
|
Ambrisentan | Ambrisentan | Cardiovascular System | No data available |
|
AmcoMin 500microgram tablets
0901020T0BEAAAG
|
AmcoMin | Mecobalamin | Nutrition and Blood | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.